Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ettrich, Thomas"'
Autor:
Masetti M; Klinikum rechts der Isar, Technische Universität München, Klinik für Innere Medizin III, Munich, Germany., Al-Batran SE; Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany and Krankenhaus Nordwest, University Cancer Center Frankfurt, Frankfurt, Germany., Goetze TO; Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany and Krankenhaus Nordwest, University Cancer Center Frankfurt, Frankfurt, Germany., Thuss-Patience P; Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité-Universitätsmedizin Berlin, Berlin, Germany., Knorrenschild JR; Klinik für Innere Medizin, Universitätsklinikum Marburg, Marburg, Germany., Goekkurt E; Haematologisch-Onkologische Praxis Eppendorf, Universitäres Cancer Center Hamburg (UCCH), Hamburg, Germany., Folprecht G; Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany., Ettrich TJ; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Lindig U; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Luley KB; UKSH Campus Lübeck, Klinik für Hämatologie und Onkologie, Lübeck, Germany., Pink D; Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie, Transplantationszentrum, Palliativmedizin, Universität Greifswald and Klinik für Hämatologie, Onkologie und Palliativmedizin-Sarkomzentrum, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany., Dechow T; Onkologie Ravensburg, Ravensburg, Germany., Sookthai D; Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Junge S; Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Loose M; Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Pauligk C; Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Lorenzen S; Klinikum rechts der Isar, Technische Universität München, Klinik für Innere Medizin III, Munich, Germany.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Jun 15; Vol. 154 (12), pp. 2142-2150. Date of Electronic Publication: 2024 Mar 06.
Autor:
Lorenzen S; Klinikum rechts der Isar, Klinik für Innere Medizin III, Technische Universität München, Munich, Germany., Götze TO; Frankfurter Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany.; Krankenhaus Nordwest, University Cancer Center Frankfurt, Frankfurt, Germany., Thuss-Patience P; Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité-Universitätsmedizin Berlin, Berlin, Germany., Biebl M; Chirurgische Klinik, Charité-Universitätsmedizin Berlin, Berlin, Germany., Homann N; Klinikum Wolfsburg, MED. Klinik II, Wolfsburg, Germany., Schenk M; Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Germany., Lindig U; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Heuer V; St Anna Hospital Herne, Herne, Germany., Kretzschmar A; MVZ Mitte, Onkologische Schwerpunktpraxis, Leipzig, Germany., Goekkurt E; Haematologisch-Onkologische Praxis Eppendorf, Universitäres Cancer Center Hamburg (UCCH), Hamburg, Germany., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Riera-Knorrenschild J; Klinik für Innere Medizin, Universitätsklinikum Marburg, Marburg, Germany., Bolling C; Agaplesion Markus Krankenhaus, Hämatologie/Onkologie, Frankfurt, Germany., Hofheinz RD; Tagestherapiezentrum am ITM, Universitätsmedizin Mannheim, Mannheim, Germany., Zhan T; Medizinische Klinik II, Universitätsmedizin Mannheim, Mannheim, Germany., Angermeier S; RKH-Kliniken Ludwigsburg, Klinik für Hämatologie und Onkologie, Ludwigsburg, Germany., Ettrich TJ; Klinik für Innere Medizin I, Universitätsklinikum Ulm, Ulm, Germany., Siebenhuener AR; Klinik für Hämatologie und Onkologie, Hirslanden Zurich AG, Zurich, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Elshafei M; Krankenhaus Nordwest, Speiseröhrenkrebszentrum, Frankfurt, Germany., Bechstein WO; Klinik für Allgemein- und Viszeral-, Transplantations- und Thoraxchirurgie, Universitätsklinikum Frankfurt, Frankfurt, Germany., Gaiser T; Institut für Pathologie, Universitätsmedizin Mannheim, Mannheim, Germany., Loose M; Frankfurter Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Sookthai D; Frankfurter Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Kopp C; Frankfurter Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Pauligk C; Frankfurter Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany., Al-Batran SE; Frankfurter Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany.; Krankenhaus Nordwest, University Cancer Center Frankfurt, Frankfurt, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Feb 01; Vol. 42 (4), pp. 410-420. Date of Electronic Publication: 2023 Nov 14.
Autor:
Heinrich K; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Heinemann V; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Stintzing S; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg, Germany., Müller L; Oncology Practice UnterEms, Leer, Germany., Ettrich TJ; Department of Internal Medicine I, University of Ulm, Ulm, Germany., Büchner-Steudel P; Martin-Luther-University Halle Wittenberg, Medizinische Fakultät, Universitätsklinik und Poliklinik für Innere Medizin I, Halle (Saale), Germany., Geißler M; Hospital Karlsruhe, Karlsruhe, Germany., Trojan J; Medical Clinic 1, Goethe University Hospital, Frankfurt am Main, Germany., Moosmann N; Department of Hematology and Oncology, Krankenhaus Barmherzige Brüder, Regensburg, Germany., Folprecht G; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany., Schmidt J; Department of Surgery, LAKUMED, Teaching Hospital Technical University Munich (TUM), Landshut, Germany., Kanzler S; Department of Internal Medicine II, Leopoldina Krankenhaus Schweinfurt, Schweinfurt, Germany., Kullmann F; Department of Medicine I, Klinikum Weiden, Weiden, Germany., Moulin JC; Ortenau Klinikum Lahr, Medizinische Klinik, Sektion Hämatologie/Onkologie, Lahr, Germany., Werner J; Department of General, Visceral and Transplantation Surgery, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Angele MK; Department of General, Visceral and Transplantation Surgery, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Probst V; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Held S; ClinAssess GmbH, Department of Biometry, Leverkusen, Germany., Schulz C; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Internal Medicine II, Hospital Ingolstadt, Ingolstadt, Germany., Boukovala M; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Publikováno v:
Oncology research and treatment [Oncol Res Treat] 2024; Vol. 47 (6), pp. 251-261. Date of Electronic Publication: 2024 Apr 02.
Autor:
Hofheinz RD; Mannheim Cancer Center, University Hospital Mannheim, Mannheim, Germany., Merx K; Mannheim Cancer Center, University Hospital Mannheim, Mannheim, Germany., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Ettrich T; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Borchert K; Department of Hematology/ Oncology, Hospital Magdeburg gGmbH, Magdeburg, Germany., Kretzschmar A; Oncology, ÜBAG MVZ Mitte, Leipzig, Germany., Teschendorf C; Department of Internal Medicine, St.-Josefs-Hospital, Dortmund, Germany., Siegler G; Department of Internal Medicine 5, Hematology/ Oncology, Hospital Nürnberg Nord/Paracelsus Medical University, Nürnberg, Germany., Ebert MP; Mannheim Cancer Center, University Hospital Mannheim, Mannheim, Germany.; Medical Department II, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center, Mannheim, Germany., Goekkurt E; Hematology-Oncology Practice, Specialist Center Eppendorf, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Mahlberg R; Medical Department I, Hospital Mutterhaus Trier, Trier, Germany., Homann N; Medical Department II, Hospital Wolfsburg, Wolfsburg, Germany., Pink D; Sarcoma Center Berlin-Brandenburg, Helios Hospital Bad Saarow, Bad Saarow, Germany.; Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany., Bechstein W; Department of General and Visceral Surgery, Frankfurt University Hospital, Frankfurt am Main, Germany., Reichardt P; Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Berlin Buch, Berlin, Germany., Flach H; Department of Hematology and Oncology, Pius Hospital, University Hospital Oldenburg, Oldenburg, Germany., Gaiser T; Institute of Pathology, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany., Battmann A; Institute of Pathology, Hospital Northwest, Frankfurt am Main, Germany., Oduncu FS; Department of Hematology and Oncology, Medizinische Klinik und Poliklinik III, University Hospital München, München, Germany., Loose M; Institute for Clinical Cancer Research IKF at Hospital Northwest, Frankfurt am Main, Germany., Sookthai D; Institute for Clinical Cancer Research IKF at Hospital Northwest, Frankfurt am Main, Germany., Pauligk C; Institute for Clinical Cancer Research IKF at Hospital Northwest, Frankfurt am Main, Germany., Göetze TO; Institute for Clinical Cancer Research IKF at Hospital Northwest, Frankfurt am Main, Germany.; UCT-University Cancer Center, Hospital Northwest, Frankfurt am Main, Germany., Al-Batran SE; Institute for Clinical Cancer Research IKF at Hospital Northwest, Frankfurt am Main, Germany.; UCT-University Cancer Center, Hospital Northwest, Frankfurt am Main, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Nov 10; Vol. 40 (32), pp. 3750-3761. Date of Electronic Publication: 2022 Jun 16.
Autor:
Lorenzen S; Klinikum Rechts der Isar, Technische Universität München, III. Medizinische Klinik und Poliklinik, München, Germany. Electronic address: sylvielorenzen@gmx.de., Thuss-Patience P; Charité - Universitätsmedizin Berlin/Campus Virchow Klinikum (CVK), Med. Klinik M. S. Hämatologie, Onkologie und Tumorimmunologie (CC14), Berlin, Germany., Pauligk C; Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest, Frankfurt, Germany., Gökkurt E; Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Facharztzentrum Eppendorf, Hamburg, Germany., Ettrich T; Universitätsklinikum Ulm, Klinik für Innere Medizin I, Ulm, Germany., Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Leipzig, Germany., Stahl M; Evang. Kliniken Essen-Mitte, Klinik für Internistische Onkologie und Hämatologie, Essen, Germany., Reichardt P; HELIOS Klinikum Berlin Buch, Klinik für Interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg, Berlin, Germany., Sökler M; Universitätsklinikum Tübingen, Medizinische Klinik II, Tübingen, Germany., Pink D; Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie, Transplantationszentrum, Palliativmedizin, Universität Greifswald, Greifswald, Germany; Klinik für Hämatologie, Onkologie und Palliativmedizin, Sarkomzentrum Berlin-Brandenburg, HELIOS Klinikum Bad-Saarow, Bad Saarow, Germany., Probst S; Klinikum Bielefeld Mitte, Klinik für Hämatologie, Onkologie U. Palliativmedizin, Bielefeld, Germany., Hinke A; CCRC Cancer Clinical Research Consulting, Düsseldorf, Germany., Goetze TO; Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest, Frankfurt, Germany; Krankenhaus Nordwest, Frankfurt, Germany., Al-Batran SE; Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest, Frankfurt, Germany; Krankenhaus Nordwest, Frankfurt, Germany.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Apr; Vol. 165, pp. 48-57. Date of Electronic Publication: 2022 Feb 21.
Autor:
Tintelnot J; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hubertus Wald Tumorzentrum/UCCH, Martinistr. 52, 20246, Hamburg, Germany., Goekkurt E; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hubertus Wald Tumorzentrum/UCCH, Martinistr. 52, 20246, Hamburg, Germany.; Hematology-Oncology Practice Hamburg (HOPE), Hamburg, Germany., Binder M; University Hospital Halle-Wittenberg, Halle, Germany., Thuss-Patience P; Charité, University Medicine Berlin, Berlin, Germany., Lorenzen S; Rechts der Isar Hospital, Technical University of Munich, Munich, Germany., Knorrenschild JR; University Hospital of Giessen and Marburg, Marburg, Germany., Kretzschmar A; MVZ Mitte, Practice for Hematology and Oncology, Leipzig, Germany., Ettrich T; University Hospital Ulm, Ulm, Germany., Lindig U; University Hospital Jena, Jena, Germany., Jacobasch L; Practice of Hematology and Oncology, Dresden, Germany., Pink D; Helios Clinic Bad Saarow, Bad Saarow, Germany and University Medicine Greifswald, Greifswald, Germany., Al-Batran SE; Krankenhaus Nordwest, UCT University Cancer Center, Frankfurt, Germany., Hinke A; CCRC, Düsseldorf, Germany., Hegewisch-Becker S; Hematology-Oncology Practice Hamburg (HOPE), Hamburg, Germany., Nilsson S; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hubertus Wald Tumorzentrum/UCCH, Martinistr. 52, 20246, Hamburg, Germany., Bokemeyer C; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hubertus Wald Tumorzentrum/UCCH, Martinistr. 52, 20246, Hamburg, Germany., Stein A; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hubertus Wald Tumorzentrum/UCCH, Martinistr. 52, 20246, Hamburg, Germany. a.stein@uke.de.; Hematology-Oncology Practice Hamburg (HOPE), Hamburg, Germany. a.stein@uke.de.
Publikováno v:
BMC cancer [BMC Cancer] 2020 Jun 01; Vol. 20 (1), pp. 503. Date of Electronic Publication: 2020 Jun 01.